Fox Run Management’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-12,903
Closed -$141K 1130
2024
Q3
$141K Sell
12,903
-316
-2% -$3.21K 0.03% 706
2024
Q2
$119K Sell
13,219
-10,368
-44% -$72.3K 0.02% 713
2024
Q1
$193K Buy
+23,587
New +$193K 0.04% 642
2023
Q2
Sell
-10,832
Closed -$191K 913
2023
Q1
$191K Buy
+10,832
New +$258K 0.06% 538

Other funds holding REPL

Fox Run Management's REPL Position: Q4 2024 in Review

Fox Run Management sold out of Replimune Group (REPL) in Q4 2024, closing a stake of 12,903 shares — an estimated $141K sold.

Fox Run Management first reported a position in REPL in Q1 2023 and held it in 4 quarters. The position peaked at $193K in Q1 2024. 157 funds tracked by Wall St. Rank hold REPL as of Q4 2024.

  • Fox Run Management reported no remaining Replimune Group position as of Q4 2024 after selling out during the quarter.
  • Fox Run Management sold 12,903 Replimune Group shares in Q4 2024, an estimated $141K.
  • Fox Run Management first reported a position in Replimune Group in Q1 2023 and held it in 4 quarters.
  • Fox Run Management's Replimune Group position peaked at $193K in Q1 2024.
  • 157 funds tracked by Wall St. Rank held Replimune Group as of Q4 2024.

Based on Fox Run Management's 13F filing for Q4 2024, filed 11 Feb 2025.